• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抑制 GDP-D-甘露糖 4,6-脱水酶和β-1,2-木糖基转移酶基因来去除植物 N-聚糖中的植物特异性糖残基。

Deletion of plant-specific sugar residues in plant N-glycans by repression of GDP-D-mannose 4,6-dehydratase and β-1,2-xylosyltransferase genes.

机构信息

Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2-17-2-1 Tsukisamu-Higashi, Toyohira-ku, Sapporo 062-8517, Japan.

Agroscience Research Laboratories, Hokusan Co., Ltd., 27-4, Kitanosato, Kitahiroshima, Hokkaido 061-1111, Japan.

出版信息

J Biosci Bioeng. 2014 Oct;118(4):448-54. doi: 10.1016/j.jbiosc.2014.04.005. Epub 2014 May 3.

DOI:10.1016/j.jbiosc.2014.04.005
PMID:24794851
Abstract

Production of pharmaceutical glycoproteins, such as therapeutic antibodies and cytokines, in plants has many advantages in safety and reduced costs. However, plant-made glycoproteins have N-glycans with plant-specific sugar residues (core β-1,2-xylose and α-1,3-fucose) and a Lewis a (Le(a)) epitope, Galβ(1-3)[Fucα(1-4)]GlcNAc. Because it is likely that these sugar residues and glycan structures are immunogenic, many attempts have been made to delete them. Previously, we reported the simultaneous deletion of the plant-specific core α-1,3-fucose and α-1,4-fucose residues in Le(a) epitopes by repressing the GDP-D-mannose 4,6-dehydratase (GMD) gene, which is associated with GDP-L-fucose biosynthesis, in Nicotiana benthamiana plants (rGMD plants, renamed to ΔGMD plants) (Matsuo and Matsumura, Plant Biotechnol. J., 9, 264-281, 2011). In the present study, we generated a core β-1,2-xylose residue-repressed transgenic N. benthamiana plant by co-suppression of β-1,2-xylosyltransferase (ΔXylT plant). By crossing ΔGMD and ΔXylT plants, we successfully generated plants in which plant-specific sugar residues were repressed (ΔGMDΔXylT plants). The proportion of N-glycans with deleted plant-specific sugar residues found in total soluble protein from ΔGMDΔXylT plants increased by 82.41%. Recombinant mouse granulocyte/macrophage-colony stimulating factor (mGM-CSF) and human monoclonal immunoglobulin G (hIgG) harboring N-glycans with deleted plant-specific sugar residues were successfully produced in ΔGMDΔXylT plants. Simultaneous repression of the GMD and XylT genes in N. benthamiana is thus very useful for deleting plant-specific sugar residues.

摘要

生产药用糖蛋白,如治疗性抗体和细胞因子,在植物中有许多优势,在安全性和降低成本。然而,植物制造的糖蛋白具有植物特异性糖残基(核心β-1,2-木糖和α-1,3-岩藻糖)和 Lewis a(Le(a))表位,Galβ(1-3)[Fucα(1-4)]GlcNAc。由于这些糖残基和聚糖结构可能具有免疫原性,因此已经进行了许多尝试来删除它们。以前,我们通过抑制与 GDP-L-岩藻糖生物合成相关的 GDP-D-甘露糖 4,6-脱水酶(GMD)基因,在 Nicotiana benthamiana 植物中同时删除了 Le(a)表位中的植物特异性核心α-1,3-岩藻糖和α-1,4-岩藻糖残基(rGMD 植物,重命名为ΔGMD 植物)(Matsuo 和 Matsumura,植物生物技术杂志,9,264-281,2011)。在本研究中,我们通过共抑制β-1,2-木糖基转移酶(ΔXylT 植物)生成了核心β-1,2-木糖残基抑制的转基因 N. benthamiana 植物。通过杂交ΔGMD 和ΔXylT 植物,我们成功生成了植物特异性糖基被抑制的植物(ΔGMDΔXylT 植物)。从ΔGMDΔXylT 植物的总可溶性蛋白中发现的具有删除的植物特异性糖残基的 N-糖链的比例增加了 82.41%。成功在ΔGMDΔXylT 植物中生产了具有删除的植物特异性糖残基的重组小鼠粒细胞/巨噬细胞集落刺激因子(mGM-CSF)和人单克隆免疫球蛋白 G(hIgG)。因此,在 N. benthamiana 中同时抑制 GMD 和 XylT 基因对于删除植物特异性糖基非常有用。

相似文献

1
Deletion of plant-specific sugar residues in plant N-glycans by repression of GDP-D-mannose 4,6-dehydratase and β-1,2-xylosyltransferase genes.通过抑制 GDP-D-甘露糖 4,6-脱水酶和β-1,2-木糖基转移酶基因来去除植物 N-聚糖中的植物特异性糖残基。
J Biosci Bioeng. 2014 Oct;118(4):448-54. doi: 10.1016/j.jbiosc.2014.04.005. Epub 2014 May 3.
2
Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference.利用病毒诱导的基因沉默和 RNA 干扰技术抑制 GDP-甘露糖 4,6-脱水酶基因表达,去除植物 N-聚糖中的岩藻糖残基。
Plant Biotechnol J. 2011 Feb;9(2):264-81. doi: 10.1111/j.1467-7652.2010.00553.x. Epub 2010 Aug 19.
3
Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure.用具有类似人源 N-糖型结构的水稻细胞悬浮培养生产重组人粒细胞巨噬细胞集落刺激因子。
Plant Biotechnol J. 2011 Dec;9(9):1109-19. doi: 10.1111/j.1467-7652.2011.00636.x. Epub 2011 Aug 1.
4
CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.利用 CRISPR/Cas9 技术在本氏烟中敲除六个糖基转移酶基因,以生产缺乏 β-1,2-木糖和核心 α-1,3-岩藻糖的重组蛋白。
Plant Biotechnol J. 2019 Feb;17(2):350-361. doi: 10.1111/pbi.12981. Epub 2018 Aug 11.
5
Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production.用于糖基工程和单克隆抗体制备的本氏烟草多重靶向基因编辑
Plant Biotechnol J. 2016 Feb;14(2):533-42. doi: 10.1111/pbi.12403. Epub 2015 May 25.
6
Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins.建立一种不含植物特异性木糖和岩藻糖的烟草BY2细胞系,作为生产生物治疗蛋白的平台。
Plant Biotechnol J. 2017 Sep;15(9):1120-1129. doi: 10.1111/pbi.12702. Epub 2017 Mar 3.
7
N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants.在转基因烟草植株中表达的小鼠IgG的N-糖基化。
Glycobiology. 1999 Apr;9(4):365-72. doi: 10.1093/glycob/9.4.365.
8
The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants.在糖基工程改造的本氏烟草植株中生产人源葡萄糖脑苷脂酶。
Plant Biotechnol J. 2016 Aug;14(8):1682-94. doi: 10.1111/pbi.12529. Epub 2016 Feb 12.
9
Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation.大鼠β(1,4)-N-乙酰葡糖胺基转移酶III在烟草中的表达重塑了植物特异性N-糖基化。
Plant Biotechnol J. 2009 Jan;7(1):33-48. doi: 10.1111/j.1467-7652.2008.00370.x. Epub 2008 Sep 3.
10
Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose.生成具有复杂N-聚糖的拟南芥植物,这些N-聚糖缺乏β1,2-连接的木糖和核心α1,3-连接的岩藻糖。
FEBS Lett. 2004 Mar 12;561(1-3):132-6. doi: 10.1016/S0014-5793(04)00150-4.

引用本文的文献

1
Plant-made pharmaceuticals.植物源药物。
Plant Biotechnol (Tokyo). 2024 Sep 25;41(3):243-260. doi: 10.5511/plantbiotechnology.24.0716a.
2
A Supramolecular Platform Technology for Bacterial Cell Surface Modification.一种用于细菌细胞表面修饰的超分子平台技术。
ACS Infect Dis. 2020 Jul 10;6(7):1734-1744. doi: 10.1021/acsinfecdis.9b00523. Epub 2020 May 15.
3
NMR-based structural validation of therapeutic antibody produced in Nicotiana benthamiana.基于核磁共振的本氏烟草中产生的治疗性抗体的结构验证
Plant Cell Rep. 2015 Jun;34(6):959-68. doi: 10.1007/s00299-015-1757-1. Epub 2015 Feb 18.